EverHint — Aggressive Momentum - November 10, 2025
November 10, 2025
What this signal is (quick)
We’re screening near 52-week highs with confirming volume and contained volatility to capture fast trend continuation:
- Near high: within 5% of the 52-week high.
- Volume thrust ≥ 1.5×: today’s activity vs. recent average.
- Volatility band: 63-day vol between 0.15 and 1.00 (reduces chaotic outliers).
- Liquidity: ADV20 ≥ $10M tradeable.
- Earnings buffer: at least 3 days from the next report to avoid binary prints.
- Universe capped to Top 100 by the scan.
Idea: momentum that’s hugging highs and getting fresh participation tends to trend; this scan aims to find those names early while filtering illiquid and overly whippy tickers.
Today’s signals use end-of-day data for November 10, 2025, and this scanner remains experimental while we refine performance tracking.
How we ranked today (reader version)
- Primary sort: composite momentum score from the screen.
- Tie-breakers: higher Volume Thrust, then % of 52-W High.
- Overlays: 90-day Insider Net (open-market buys − sells), Days → Earnings, and 30-day analyst-update cadence.
- Headlines: most recent corporate news to confirm or challenge the move.
Note: Signals are for educational use and back-testing. We’ll keep tuning signal weights as live data accrues.
📈 Buy-Side Candidates — Aggressive Momentum
(Top 12 from today’s screen)
| # | Ticker | Company | Sector | Last ($) | % of 52-W High | Volume Thrust | Insider Net (USD, 90d) | Days → Earnings | Analyst Updates (30d) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LITE | Lumentum Holdings Inc. | Technology | 259.89 | 100.00% | 1.59 | — | 87 | — |
| 2 | ESTA | Establishment Labs Holdings Inc. | Healthcare | 67.69 | 100.00% | 1.59 | — | 86 | — |
| 3 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 43.48 | 100.00% | 1.52 | — | 86 | — |
| 4 | HTHT | H World Group Limited | Consumer Cyclical | 44.61 | 100.00% | 2.37 | — | 7 | — |
| 5 | SPXC | SPX Technologies, Inc. | Industrials | 224.93 | 99.57% | 1.67 | — | 86 | — |
| 6 | URGN | UroGen Pharma Ltd. | Healthcare | 23.13 | 98.26% | 2.15 | −45,692 | — | — |
| 7 | ENS | EnerSys | Industrials | 134.82 | 100.00% | 1.73 | — | 86 | — |
| 8 | APPN | Appian Corporation | Technology | 42.32 | 99.74% | 1.57 | — | 87 | — |
| 9 | COHU | Cohu, Inc. | Technology | 24.32 | 100.00% | 1.51 | — | 86 | — |
| 10 | PAHC | Phibro Animal Health Corporation | Healthcare | 45.83 | 99.87% | 1.56 | −1,595,226 | 86 | — |
| 11 | PTCT | PTC Therapeutics, Inc. | Healthcare | 72.48 | 99.85% | 1.70 | −2,253,343 | — | — |
| 12 | FSLY | Fastly, Inc. | Technology | 11.93 | 100.00% | 1.62 | −1,126,667 | — | — |
Field notes
- Insider Net (USD, 90d) = sum of open-market purchases (P) minus sales (S) filed over the last 90 days.
- Days → Earnings = days until the next scheduled earnings date (if available).
- Analyst Updates (30d) = count of forecast revisions/entries in the last 30 days.
Recent Headlines (fast context)
- LITE — Lumentum: Q1 FY26 beat with 58% YoY revenue growth; Q2 outlook above consensus; shares surged post-print. (Lumentum)
- ESTA — Establishment Labs: Q3 revenue +33.8% YoY; raised 2025 revenue outlook; follow-up conference appearances this month. (Establishment Labs)
- COLL — Collegium Pharma: Q3 beat; EPS $2.25 vs $1.88 consensus per transcript recap; stock strength noted by IBD. (Insider Monkey)
- HTHT — H World Group: Q3 release set for Nov 17; longer-term “quality-driven growth” update last week. (HWorld)
- SPXC — SPX Technologies: TD Cowen initiates at Hold today; company posted Q3 results Oct 30; some outlets flagged upgrades over the weekend. (Nasdaq)
- URGN — UroGen Pharma: Reported Q3 results and phase 3 UTOPIA update showing 77.8% CR at 3 months; launch momentum commentary. (UroGen Investors)
- ENS — EnerSys: Q2 FY26 results reported Nov 6; call and webcast details posted. (EnerSys Investor Relations)
- APPN — Appian: Q3 results posted Nov 6; CEO commentary last week on responsible AI use in hiring. (Appian Investors)
- COHU — Cohu: Post-earnings coverage highlights RS rating improvement and discussion of narrowing losses and guidance. (Investors)
- PAHC — Phibro Animal Health: FQ1 results and guidance update last week; insider sales filings reported today. (Phibro Animal Health Corporation)
- PTCT — PTC Therapeutics: Q3 update Nov 4; 2025 context includes PKU drug approval (Sephience) and prior CRL on FA asset. (PTC Therapeutics)
- FSLY — Fastly: Record Q3 revenue and stronger cash generation reported Nov 5; follow-up valuation takes over the weekend. (Fastly)
📉 Sell-Side Signals — (n/a for this scan)
This screen targets long momentum only; no down-cross cohort today.
Field notes
- Consider RSI/ADX or pullback-to-MA filters before entries to avoid late chases.
- Watch for clustered earnings in the next 1–2 weeks that can add volatility.
Carlo’s Take (EverHint)
- Rotation snapshot: leadership skewed to Healthcare (5/12) and Technology (4/12), with Industrials (2/12) and one Consumer Cyclical.
- Playbook: For continuation entries, I prefer tiered adds after 2–3 daily closes holding the high-tight range and ATR-aware stops below the most recent swing low. Trim into extension spikes or volume climaxes.
- Risk tells: Heavy negative insider net in a few names (e.g., PAHC, PTCT, FSLY) argues for smaller sizing or tighter risk bands.
Independent research. No hype, no pumps, no paid promotions — just clean, data-driven signals and concise context.